Stay updated on Pembrolizumab for Leukoplakia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Leukoplakia Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:19:21.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:53:36.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:48:14.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T02:11:11.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:16:53.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed study objectives and inclusion criteria for a clinical trial involving pembrolizumab for leukoplakia, while retaining key identifiers and collaborator information.
    Difference
    52%
    Check dated 2025-04-16T20:23:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Leukoplakia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.